Praxsyn Corp (PXYN)

[Rhenarium]

This little disconnect jumps out:

PALO ALTO, CA , Jan. 9, 2014 /CNW/ - The PAWS Pet Company, Inc. (PAWS), is pleased to announce that on December 31, 2013 , PAWS closed the acquisition of Mesa Pharmacy Inc. ("Mesa").

Preliminary unaudited gross revenue numbers for fiscal year 2013 appear to have exceeded $15,000,000 , almost half of which occurred in the fourth quarter of 2013. While December is generally a slow month for Mesa, preliminary results show Mesa shipped close to $2,000,000 in prescriptions during December. Expected sales for January are expected to exceed November's sales of more than $3,000,000 . Mesa already has $2,000,000 in in prescription orders in hand which are expected to be shipped during the week of January 13, 2014.

versus:

Our revenues increased from $5,529,101 in 2012 to $6,988,536 in 2013.

As noted by another poster, the 500,000 shares of "Series D Stock" used to fund the purchase of PDC increases the fully-diluted O/S by 500,000,000.

I suspect that debt was retired by issuing other shares of Series D stock but need to read the filings in more detail. That would probably result in another few hundred million shares.

I think a reasonable guess for O/S might be around a billion shares.

ASSUMING THAT 1,000,000,000 IS A BALL-PARKISH O/S ESTIMATE...

Pick your own total 2014 earnings figure and P/E ratio to establish a price targer. Total 2014 earnings of $10M, for example, would result in EPS of $0.01.